{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:22:56Z","timestamp":1771590176189,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"DOI":"10.7759\/cureus.103960","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:59:07Z","timestamp":1771588747000},"source":"Crossref","is-referenced-by-count":0,"title":["Understanding and Managing M\u00e9ni\u00e8re\u2019s Disease: A Comprehensive Case Report"],"prefix":"10.7759","author":[{"given":"Manal M","family":"El Faham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reham","family":"Elrashidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Meniere\u2019s Disease: A Patient-Centered Guide to Decision Making","author":"Sharon JD","year":"2020","unstructured":"Sharon JD, Kirk L. Meniere\u2019s Disease: A Patient-Centered Guide to Decision Making. University of California, San Francisco, CA; 2020."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3233\/VES-150549","article-title":"Diagnostic criteria for Meni\u00e8re's disease","volume":"25","author":"Lopez-Escamez JA","year":"2015","unstructured":"Lopez-Escamez JA, Carey J, Chung WH, et al.. Diagnostic criteria for Meni\u00e8re's disease. J Vestib Res. 2015, 25:1-7. 10.3233\/VES-150549","journal-title":"J Vestib Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09301-4","article-title":"Balanced sex distribution in patients with Meni\u00e8re's disease","volume":"266","author":"Becker-Bense S","year":"2019","unstructured":"Becker-Bense S, Wittmann C, Dieterich M. Balanced sex distribution in patients with Meni\u00e8re's disease. J Neurol. 2019, 266:42-6. 10.1007\/s00415-019-09301-4","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/00016489509121906","article-title":"Epidemiological and clinical characteristics of Meni\u00e8re's disease in Japan","volume":"519","author":"Watanabe Y","year":"1995","unstructured":"Watanabe Y, Mizukoshi K, Shojaku H, Watanabe I, Hinoki M, Kitahara M. Epidemiological and clinical characteristics of Meni\u00e8re's disease in Japan. Acta Otolaryngol Suppl. 1995, 519:206-10. 10.3109\/00016489509121906","journal-title":"Acta Otolaryngol Suppl"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61161-7","article-title":"Meniere's disease","volume":"372","author":"Sajjadi H","year":"2008","unstructured":"Sajjadi H, Paparella MM. Meniere's disease. Lancet. 2008, 372:406-14. 10.1016\/S0140-6736(08)61161-7","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00129492-200501000-00013","article-title":"Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?","volume":"26","author":"Merchant SN","year":"2005","unstructured":"Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?. Otol Neurotol. 2005, 26:74-81. 10.1097\/00129492-200501000-00013","journal-title":"Otol Neurotol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-24549-9","article-title":"Hyperplastic growth, not hydrostatic distension, in endolymphatic hydrops in humans challenges the classic view of Meniere's disease","volume":"15","author":"Bryton C","year":"2025","unstructured":"Bryton C, Correa DM, B\u00e4chinger D, et al.. Hyperplastic growth, not hydrostatic distension, in endolymphatic hydrops in humans challenges the classic view of Meniere's disease. Sci Rep. 2025, 15:40801. 10.1038\/s41598-025-24549-9","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000003960","article-title":"Differential volume increase of endolymphatic compartments in M\u00e9ni\u00e8re\u2019s disease is inversely associated with membrane thickness","volume":"44","author":"B\u00fcki B","year":"2023","unstructured":"B\u00fcki B, Ward BK, Santos F. Differential volume increase of endolymphatic compartments in M\u00e9ni\u00e8re\u2019s disease is inversely associated with membrane thickness. Otol Neurotol. 2023, 44:e588-95. 10.1097\/MAO.0000000000003960","journal-title":"Otol Neurotol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2015.08.009","article-title":"Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency","volume":"43","author":"Talaat HS","year":"2016","unstructured":"Talaat HS, Kabel AM, Khaliel LH, Abuhadied G, El-Naga HA, Talaat AS. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx. 2016, 43:237-41. 10.1016\/j.anl.2015.08.009","journal-title":"Auris Nasus Larynx"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6712-2","article-title":"Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo","volume":"260","author":"Jeong SH","year":"2013","unstructured":"Jeong SH, Kim JS, Shin JW, et al.. Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol. 2013, 260:832-8. 10.1007\/s00415-012-6712-2","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010343","article-title":"Prevention of benign paroxysmal positional vertigo with vitamin D supplementation: a randomized trial","volume":"95","author":"Jeong SH","year":"2020","unstructured":"Jeong SH, Kim JS, Kim HJ, et al.. Prevention of benign paroxysmal positional vertigo with vitamin D supplementation: a randomized trial. Neurology. 2020, 95:e1117-25. 10.1212\/WNL.0000000000010343","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2012.11.029","article-title":"Vitamin D deficiency and benign paroxysmal positioning vertigo","volume":"80","author":"B\u00fcki B","year":"2013","unstructured":"B\u00fcki B, Ecker M, J\u00fcnger H, Lundberg YW. Vitamin D deficiency and benign paroxysmal positioning vertigo. Med Hypotheses. 2013, 80:201-4. 10.1016\/j.mehy.2012.11.029","journal-title":"Med Hypotheses"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.14744\/lhhs.2022.30001","article-title":"Evaluation of 25\u2011hydroxyvitamin D levels in patients with tinnitus","volume":"2","author":"\u00c7eliker M","year":"2022","unstructured":"\u00c7eliker M, Polat HB, Terzi S, et al.. Evaluation of 25\u2011hydroxyvitamin D levels in patients with tinnitus. Lokman Hekim Health Sci. 2022, 2:65-9. 10.14744\/lhhs.2022.30001","journal-title":"Lokman Hekim Health Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3182091a41","article-title":"Finnish familial Meniere disease is not linked to chromosome 12p12.3, and anticipation and cosegregation with migraine are not common findings","volume":"13","author":"Hietikko E","year":"2011","unstructured":"Hietikko E, Kotim\u00e4ki J, Kentala E, Klockars T, Sorri M, M\u00e4nnikk\u00f6 M. Finnish familial Meniere disease is not linked to chromosome 12p12.3, and anticipation and cosegregation with migraine are not common findings. Genet Med. 2011, 13:415-20. 10.1097\/GIM.0b013e3182091a41","journal-title":"Genet Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-5998(95)70102-8","article-title":"Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in M\u00e9ni\u00e8re\u2019s disease","volume":"113","author":"Committee on Hearing and Equilibrium","year":"1995","unstructured":"Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in M\u00e9ni\u00e8re\u2019s disease. Otolaryngol Head Neck Surg. 1995, 113:181-5. 10.1016\/S0194-5998(95)70102-8","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref16","article-title":"Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial","volume":"19","author":"Silverstein H","year":"1998","unstructured":"Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol. 1998, 19:196-201.","journal-title":"Am J Otol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31461-1","article-title":"Intratympanic methylprednisolone versus gentamicin in patients with unilateral M\u00e9ni\u00e8re's disease: a randomised, double-blind, comparative effectiveness trial","volume":"388","author":"Patel M","year":"2016","unstructured":"Patel M, Agarwal K, Arshad Q, et al.. Intratympanic methylprednisolone versus gentamicin in patients with unilateral M\u00e9ni\u00e8re's disease: a randomised, double-blind, comparative effectiveness trial. Lancet. 2016, 388:2753-62. 10.1016\/S0140-6736(16)31461-1","journal-title":"Lancet"},{"key":"ref18","article-title":"Physical therapy treatment of vestibular hypofunction","author":"Herdman SJ","year":"2014","unstructured":"Herdman SJ, Whitney SL. Physical therapy treatment of vestibular hypofunction. Vestibular Rehabilitation, 4th Edition. Herdman SJ, Clendaniel RA (ed): F.A. Davis, Philadelphia, PA; 2014. 452-86."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6816","article-title":"Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)","volume":"352","author":"Adrion C","year":"2016","unstructured":"Adrion C, Fischer CS, Wagner J, G\u00fcrkov R, Mansmann U, Strupp M. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016, 352:h6816. 10.1136\/bmj.h6816","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003599.pub2","article-title":"Diuretics for M\u00e9ni\u00e8re's disease or syndrome","volume":"2006","author":"Thirlwall AS","year":"2006","unstructured":"Thirlwall AS, Kundu S. Diuretics for M\u00e9ni\u00e8re's disease or syndrome. Cochrane Database Syst Rev. 2006, 2006:CD003599. 10.1002\/14651858.CD003599.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/441557-understanding-and-managing-mnires-disease-a-comprehensive-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:59:08Z","timestamp":1771588748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/441557-understanding-and-managing-mnires-disease-a-comprehensive-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.103960","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,20]]}}}